Position in NTLA
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$3,946,708
+$3,475,484 QoQ
Shares Held
233,257
+534.6% QoQ
Ownership
0.166%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#63
of 330 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Derivatives in NTLA
reported options exposure · as of Sep 30, 2023CallValue
$3,162
CallShares
100
PutValue
$158,100
PutShares
5,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $2,085,225,397 across 384 Biotechnology names. NTLA ranks #81 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
706,968 | $351,172,214 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,637 | $216,142,034 | |
| 3 | MRNA |
Moderna, Inc.
|
2,165,414 | $151,643,941 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
2,225,190 | $78,749,472 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
227,786 | $68,570,419 | |
| 6 | INCY |
Incyte Corp
|
586,431 | $66,477,817 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
864,101 | $64,358,241 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
247,052 | $46,267,897 |
All Filings in NTLA
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,946,708 | 233,257 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $471,224 | 36,757 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $2,078,090 | 231,156 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,548,564 | 89,668 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $1,358,043 | 144,781 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $2,114,555 | 297,406 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $3,229,001 | 276,930 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $3,443,357 | 167,560 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $2,425,588 | 108,382 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $9,434,993 | 342,966 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $5,110,306 | 167,606 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $158,100 | 5,000 | Put | Defined | 2023-12-06 | |
| 2023-09-30 | $8,392,073 | 265,404 | Shares | Defined | 2023-12-06 | |
| 2023-09-30 | $3,162 | 100 | Call | Defined | 2023-12-06 | |
| 2023-06-30 | $6,975,051 | 171,041 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $5,817,399 | 156,088 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $3,458,331 | 99,121 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $1,399,000 | 25,000 | Put | Defined | 2022-11-10 | |
| 2022-09-30 | $6,536,238 | 116,802 | Shares | Defined | 2022-11-10 | |
| 2022-09-30 | $1,399,000 | 25,000 | Call | Defined | 2022-11-10 | |
| 2022-06-30 | $5,253,380 | 101,495 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $24,619,577 | 338,786 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $7,765,883 | 65,679 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $9,665,774 | 72,052 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $10,817,691 | 66,813 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $5,962,142 | 74,290 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $866,700 | 15,932 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $506,164 | 25,461 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $856,690 | 40,756 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $537,617 | 43,959 | Shares | Defined | 2020-05-12 | |
| 2020-03-31 | $34,244 | 2,800 | Call | Defined | 2020-05-12 | |
| 2020-03-31 | $68,488 | 5,600 | Put | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||